GLOBAL DIAGNOSTIC NUCLEAR MEDICINES MARKET 2022 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2028

Table of Contents

1 Market Overview
1.1 Diagnostic Nuclear Medicines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Diagnostic Nuclear Medicines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Tc-99m
1.2.3 F-18
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Diagnostic Nuclear Medicines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Diagnostic Nuclear Medicines Market Size & Forecast
1.4.1 Global Diagnostic Nuclear Medicines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Diagnostic Nuclear Medicines Sales in Volume (2017-2028)
1.4.3 Global Diagnostic Nuclear Medicines Price (2017-2028)
1.5 Global Diagnostic Nuclear Medicines Production Capacity Analysis
1.5.1 Global Diagnostic Nuclear Medicines Total Production Capacity (2017-2028)
1.5.2 Global Diagnostic Nuclear Medicines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Diagnostic Nuclear Medicines Market Drivers
1.6.2 Diagnostic Nuclear Medicines Market Restraints
1.6.3 Diagnostic Nuclear Medicines Trends Analysis
2 Manufacturers Profiles
2.1 Bracco Imaging
2.1.1 Bracco Imaging Details
2.1.2 Bracco Imaging Major Business
2.1.3 Bracco Imaging Diagnostic Nuclear Medicines Product and Services
2.1.4 Bracco Imaging Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Diagnostic Nuclear Medicines Product and Services
2.2.4 Bayer Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Curium Pharmaceuticals
2.3.1 Curium Pharmaceuticals Details
2.3.2 Curium Pharmaceuticals Major Business
2.3.3 Curium Pharmaceuticals Diagnostic Nuclear Medicines Product and Services
2.3.4 Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Nordion
2.4.1 Nordion Details
2.4.2 Nordion Major Business
2.4.3 Nordion Diagnostic Nuclear Medicines Product and Services
2.4.4 Nordion Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Triad Isotopes
2.5.1 Triad Isotopes Details
2.5.2 Triad Isotopes Major Business
2.5.3 Triad Isotopes Diagnostic Nuclear Medicines Product and Services
2.5.4 Triad Isotopes Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Lantheus
2.6.1 Lantheus Details
2.6.2 Lantheus Major Business
2.6.3 Lantheus Diagnostic Nuclear Medicines Product and Services
2.6.4 Lantheus Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 GE Healthcare
2.7.1 GE Healthcare Details
2.7.2 GE Healthcare Major Business
2.7.3 GE Healthcare Diagnostic Nuclear Medicines Product and Services
2.7.4 GE Healthcare Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 China Isotope & Radiation
2.8.1 China Isotope & Radiation Details
2.8.2 China Isotope & Radiation Major Business
2.8.3 China Isotope & Radiation Diagnostic Nuclear Medicines Product and Services
2.8.4 China Isotope & Radiation Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Jubilant Pharma
2.9.1 Jubilant Pharma Details
2.9.2 Jubilant Pharma Major Business
2.9.3 Jubilant Pharma Diagnostic Nuclear Medicines Product and Services
2.9.4 Jubilant Pharma Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business
2.10.3 Eli Lilly Diagnostic Nuclear Medicines Product and Services
2.10.4 Eli Lilly Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Novartis
2.11.1 Novartis Details
2.11.2 Novartis Major Business
2.11.3 Novartis Diagnostic Nuclear Medicines Product and Services
2.11.4 Novartis Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 SIEMENS
2.12.1 SIEMENS Details
2.12.2 SIEMENS Major Business
2.12.3 SIEMENS Diagnostic Nuclear Medicines Product and Services
2.12.4 SIEMENS Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Dongcheng
2.13.1 Dongcheng Details
2.13.2 Dongcheng Major Business
2.13.3 Dongcheng Diagnostic Nuclear Medicines Product and Services
2.13.4 Dongcheng Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Navidea
2.14.1 Navidea Details
2.14.2 Navidea Major Business
2.14.3 Navidea Diagnostic Nuclear Medicines Product and Services
2.14.4 Navidea Diagnostic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Diagnostic Nuclear Medicines Breakdown Data by Manufacturer
3.1 Global Diagnostic Nuclear Medicines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Diagnostic Nuclear Medicines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Diagnostic Nuclear Medicines
3.4 Market Concentration Rate
3.4.1 Top 3 Diagnostic Nuclear Medicines Manufacturer Market Share in 2021
3.4.2 Top 6 Diagnostic Nuclear Medicines Manufacturer Market Share in 2021
3.5 Global Diagnostic Nuclear Medicines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Diagnostic Nuclear Medicines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Diagnostic Nuclear Medicines Market Size by Region
4.1.1 Global Diagnostic Nuclear Medicines Sales in Volume by Region (2017-2028)
4.1.2 Global Diagnostic Nuclear Medicines Revenue by Region (2017-2028)
4.2 North America Diagnostic Nuclear Medicines Revenue (2017-2028)
4.3 Europe Diagnostic Nuclear Medicines Revenue (2017-2028)
4.4 Asia-Pacific Diagnostic Nuclear Medicines Revenue (2017-2028)
4.5 South America Diagnostic Nuclear Medicines Revenue (2017-2028)
4.6 Middle East and Africa Diagnostic Nuclear Medicines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Diagnostic Nuclear Medicines Sales in Volume by Type (2017-2028)
5.2 Global Diagnostic Nuclear Medicines Revenue by Type (2017-2028)
5.3 Global Diagnostic Nuclear Medicines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Diagnostic Nuclear Medicines Sales in Volume by Application (2017-2028)
6.2 Global Diagnostic Nuclear Medicines Revenue by Application (2017-2028)
6.3 Global Diagnostic Nuclear Medicines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Diagnostic Nuclear Medicines Sales by Type (2017-2028)
7.2 North America Diagnostic Nuclear Medicines Sales by Application (2017-2028)
7.3 North America Diagnostic Nuclear Medicines Market Size by Country
7.3.1 North America Diagnostic Nuclear Medicines Sales in Volume by Country (2017-2028)
7.3.2 North America Diagnostic Nuclear Medicines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Diagnostic Nuclear Medicines Sales by Type (2017-2028)
8.2 Europe Diagnostic Nuclear Medicines Sales by Application (2017-2028)
8.3 Europe Diagnostic Nuclear Medicines Market Size by Country
8.3.1 Europe Diagnostic Nuclear Medicines Sales in Volume by Country (2017-2028)
8.3.2 Europe Diagnostic Nuclear Medicines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Diagnostic Nuclear Medicines Sales by Type (2017-2028)
9.2 Asia-Pacific Diagnostic Nuclear Medicines Sales by Application (2017-2028)
9.3 Asia-Pacific Diagnostic Nuclear Medicines Market Size by Region
9.3.1 Asia-Pacific Diagnostic Nuclear Medicines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Diagnostic Nuclear Medicines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Diagnostic Nuclear Medicines Sales by Type (2017-2028)
10.2 South America Diagnostic Nuclear Medicines Sales by Application (2017-2028)
10.3 South America Diagnostic Nuclear Medicines Market Size by Country
10.3.1 South America Diagnostic Nuclear Medicines Sales in Volume by Country (2017-2028)
10.3.2 South America Diagnostic Nuclear Medicines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Diagnostic Nuclear Medicines Sales by Type (2017-2028)
11.2 Middle East & Africa Diagnostic Nuclear Medicines Sales by Application (2017-2028)
11.3 Middle East & Africa Diagnostic Nuclear Medicines Market Size by Country
11.3.1 Middle East & Africa Diagnostic Nuclear Medicines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Diagnostic Nuclear Medicines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Diagnostic Nuclear Medicines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Diagnostic Nuclear Medicines
12.3 Diagnostic Nuclear Medicines Production Process
12.4 Diagnostic Nuclear Medicines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Diagnostic Nuclear Medicines Typical Distributors
13.3 Diagnostic Nuclear Medicines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Diagnostic Nuclear Medicines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Diagnostic Nuclear Medicines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 4. Bracco Imaging Major Business
Table 5. Bracco Imaging Diagnostic Nuclear Medicines Product and Services
Table 6. Bracco Imaging Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Bayer Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Major Business
Table 9. Bayer Diagnostic Nuclear Medicines Product and Services
Table 10. Bayer Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Curium Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Curium Pharmaceuticals Major Business
Table 13. Curium Pharmaceuticals Diagnostic Nuclear Medicines Product and Services
Table 14. Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Nordion Basic Information, Manufacturing Base and Competitors
Table 16. Nordion Major Business
Table 17. Nordion Diagnostic Nuclear Medicines Product and Services
Table 18. Nordion Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Triad Isotopes Basic Information, Manufacturing Base and Competitors
Table 20. Triad Isotopes Major Business
Table 21. Triad Isotopes Diagnostic Nuclear Medicines Product and Services
Table 22. Triad Isotopes Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Lantheus Basic Information, Manufacturing Base and Competitors
Table 24. Lantheus Major Business
Table 25. Lantheus Diagnostic Nuclear Medicines Product and Services
Table 26. Lantheus Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 28. GE Healthcare Major Business
Table 29. GE Healthcare Diagnostic Nuclear Medicines Product and Services
Table 30. GE Healthcare Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 32. China Isotope & Radiation Major Business
Table 33. China Isotope & Radiation Diagnostic Nuclear Medicines Product and Services
Table 34. China Isotope & Radiation Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 36. Jubilant Pharma Major Business
Table 37. Jubilant Pharma Diagnostic Nuclear Medicines Product and Services
Table 38. Jubilant Pharma Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 40. Eli Lilly Major Business
Table 41. Eli Lilly Diagnostic Nuclear Medicines Product and Services
Table 42. Eli Lilly Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Novartis Basic Information, Manufacturing Base and Competitors
Table 44. Novartis Major Business
Table 45. Novartis Diagnostic Nuclear Medicines Product and Services
Table 46. Novartis Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 48. SIEMENS Major Business
Table 49. SIEMENS Diagnostic Nuclear Medicines Product and Services
Table 50. SIEMENS Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 52. Dongcheng Major Business
Table 53. Dongcheng Diagnostic Nuclear Medicines Product and Services
Table 54. Dongcheng Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Navidea Basic Information, Manufacturing Base and Competitors
Table 56. Navidea Major Business
Table 57. Navidea Diagnostic Nuclear Medicines Product and Services
Table 58. Navidea Diagnostic Nuclear Medicines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global Diagnostic Nuclear Medicines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 60. Global Diagnostic Nuclear Medicines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in Diagnostic Nuclear Medicines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global Diagnostic Nuclear Medicines Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Diagnostic Nuclear Medicines Production Site of Key Manufacturer
Table 64. Diagnostic Nuclear Medicines New Entrant and Capacity Expansion Plans
Table 65. Diagnostic Nuclear Medicines Mergers & Acquisitions in the Past Five Years
Table 66. Global Diagnostic Nuclear Medicines Sales by Region (2017-2022) & (K Units)
Table 67. Global Diagnostic Nuclear Medicines Sales by Region (2023-2028) & (K Units)
Table 68. Global Diagnostic Nuclear Medicines Revenue by Region (2017-2022) & (USD Million)
Table 69. Global Diagnostic Nuclear Medicines Revenue by Region (2023-2028) & (USD Million)
Table 70. Global Diagnostic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
Table 71. Global Diagnostic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
Table 72. Global Diagnostic Nuclear Medicines Revenue by Type (2017-2022) & (USD Million)
Table 73. Global Diagnostic Nuclear Medicines Revenue by Type (2023-2028) & (USD Million)
Table 74. Global Diagnostic Nuclear Medicines Price by Type (2017-2022) & (USD/Unit)
Table 75. Global Diagnostic Nuclear Medicines Price by Type (2023-2028) & (USD/Unit)
Table 76. Global Diagnostic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
Table 77. Global Diagnostic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
Table 78. Global Diagnostic Nuclear Medicines Revenue by Application (2017-2022) & (USD Million)
Table 79. Global Diagnostic Nuclear Medicines Revenue by Application (2023-2028) & (USD Million)
Table 80. Global Diagnostic Nuclear Medicines Price by Application (2017-2022) & (USD/Unit)
Table 81. Global Diagnostic Nuclear Medicines Price by Application (2023-2028) & (USD/Unit)
Table 82. North America Diagnostic Nuclear Medicines Sales by Country (2017-2022) & (K Units)
Table 83. North America Diagnostic Nuclear Medicines Sales by Country (2023-2028) & (K Units)
Table 84. North America Diagnostic Nuclear Medicines Revenue by Country (2017-2022) & (USD Million)
Table 85. North America Diagnostic Nuclear Medicines Revenue by Country (2023-2028) & (USD Million)
Table 86. North America Diagnostic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
Table 87. North America Diagnostic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
Table 88. North America Diagnostic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
Table 89. North America Diagnostic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
Table 90. Europe Diagnostic Nuclear Medicines Sales by Country (2017-2022) & (K Units)
Table 91. Europe Diagnostic Nuclear Medicines Sales by Country (2023-2028) & (K Units)
Table 92. Europe Diagnostic Nuclear Medicines Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe Diagnostic Nuclear Medicines Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe Diagnostic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
Table 95. Europe Diagnostic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
Table 96. Europe Diagnostic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
Table 97. Europe Diagnostic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
Table 98. Asia-Pacific Diagnostic Nuclear Medicines Sales by Region (2017-2022) & (K Units)
Table 99. Asia-Pacific Diagnostic Nuclear Medicines Sales by Region (2023-2028) & (K Units)
Table 100. Asia-Pacific Diagnostic Nuclear Medicines Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific Diagnostic Nuclear Medicines Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific Diagnostic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
Table 103. Asia-Pacific Diagnostic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
Table 104. Asia-Pacific Diagnostic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
Table 105. Asia-Pacific Diagnostic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
Table 106. South America Diagnostic Nuclear Medicines Sales by Country (2017-2022) & (K Units)
Table 107. South America Diagnostic Nuclear Medicines Sales by Country (2023-2028) & (K Units)
Table 108. South America Diagnostic Nuclear Medicines Revenue by Country (2017-2022) & (USD Million)
Table 109. South America Diagnostic Nuclear Medicines Revenue by Country (2023-2028) & (USD Million)
Table 110. South America Diagnostic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
Table 111. South America Diagnostic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
Table 112. South America Diagnostic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
Table 113. South America Diagnostic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
Table 114. Middle East & Africa Diagnostic Nuclear Medicines Sales by Region (2017-2022) & (K Units)
Table 115. Middle East & Africa Diagnostic Nuclear Medicines Sales by Region (2023-2028) & (K Units)
Table 116. Middle East & Africa Diagnostic Nuclear Medicines Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa Diagnostic Nuclear Medicines Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa Diagnostic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
Table 119. Middle East & Africa Diagnostic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
Table 120. Middle East & Africa Diagnostic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
Table 121. Middle East & Africa Diagnostic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
Table 122. Diagnostic Nuclear Medicines Raw Material
Table 123. Key Manufacturers of Diagnostic Nuclear Medicines Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Diagnostic Nuclear Medicines Typical Distributors
Table 127. Diagnostic Nuclear Medicines Typical Customers
List of Figures
Figure 1. Diagnostic Nuclear Medicines Picture
Figure 2. Global Diagnostic Nuclear Medicines Revenue Market Share by Type in 2021
Figure 3. Tc-99m
Figure 4. F-18
Figure 5. Other
Figure 6. Global Diagnostic Nuclear Medicines Revenue Market Share by Application in 2021
Figure 7. Oncology
Figure 8. Cardiology
Figure 9. Other
Figure 10. Global Diagnostic Nuclear Medicines Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Diagnostic Nuclear Medicines Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Diagnostic Nuclear Medicines Sales (2017-2028) & (K Units)
Figure 13. Global Diagnostic Nuclear Medicines Price (2017-2028) & (USD/Unit)
Figure 14. Global Diagnostic Nuclear Medicines Production Capacity (2017-2028) & (K Units)
Figure 15. Global Diagnostic Nuclear Medicines Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Diagnostic Nuclear Medicines Market Drivers
Figure 17. Diagnostic Nuclear Medicines Market Restraints
Figure 18. Diagnostic Nuclear Medicines Market Trends
Figure 19. Global Diagnostic Nuclear Medicines Sales Market Share by Manufacturer in 2021
Figure 20. Global Diagnostic Nuclear Medicines Revenue Market Share by Manufacturer in 2021
Figure 21. Diagnostic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Diagnostic Nuclear Medicines Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Diagnostic Nuclear Medicines Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Diagnostic Nuclear Medicines Sales Market Share by Region (2017-2028)
Figure 25. Global Diagnostic Nuclear Medicines Revenue Market Share by Region (2017-2028)
Figure 26. North America Diagnostic Nuclear Medicines Revenue (2017-2028) & (USD Million)
Figure 27. Europe Diagnostic Nuclear Medicines Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Diagnostic Nuclear Medicines Revenue (2017-2028) & (USD Million)
Figure 29. South America Diagnostic Nuclear Medicines Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Diagnostic Nuclear Medicines Revenue (2017-2028) & (USD Million)
Figure 31. Global Diagnostic Nuclear Medicines Sales Market Share by Type (2017-2028)
Figure 32. Global Diagnostic Nuclear Medicines Revenue Market Share by Type (2017-2028)
Figure 33. Global Diagnostic Nuclear Medicines Price by Type (2017-2028) & (USD/Unit)
Figure 34. Global Diagnostic Nuclear Medicines Sales Market Share by Application (2017-2028)
Figure 35. Global Diagnostic Nuclear Medicines Revenue Market Share by Application (2017-2028)
Figure 36. Global Diagnostic Nuclear Medicines Price by Application (2017-2028) & (USD/Unit)
Figure 37. North America Diagnostic Nuclear Medicines Sales Market Share by Type (2017-2028)
Figure 38. North America Diagnostic Nuclear Medicines Sales Market Share by Application (2017-2028)
Figure 39. North America Diagnostic Nuclear Medicines Sales Market Share by Country (2017-2028)
Figure 40. North America Diagnostic Nuclear Medicines Revenue Market Share by Country (2017-2028)
Figure 41. United States Diagnostic Nuclear Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Diagnostic Nuclear Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Diagnostic Nuclear Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Diagnostic Nuclear Medicines Sales Market Share by Type (2017-2028)
Figure 45. Europe Diagnostic Nuclear Medicines Sales Market Share by Application (2017-2028)
Figure 46. Europe Diagnostic Nuclear Medicines Sales Market Share by Country (2017-2028)
Figure 47. Europe Diagnostic Nuclear Medicines Revenue Market Share by Country (2017-2028)
Figure 48. Germany Diagnostic Nuclear Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Diagnostic Nuclear Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Diagnostic Nuclear Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Diagnostic Nuclear Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Diagnostic Nuclear Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Diagnostic Nuclear Medicines Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Diagnostic Nuclear Medicines Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Diagnostic Nuclear Medicines Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Diagnostic Nuclear Medicines Revenue Market Share by Region (2017-2028)
Figure 57. China Diagnostic Nuclear Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Diagnostic Nuclear Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Diagnostic Nuclear Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Diagnostic Nuclear Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Diagnostic Nuclear Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Diagnostic Nuclear Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Diagnostic Nuclear Medicines Sales Market Share by Type (2017-2028)
Figure 64. South America Diagnostic Nuclear Medicines Sales Market Share by Application (2017-2028)
Figure 65. South America Diagnostic Nuclear Medicines Sales Market Share by Country (2017-2028)
Figure 66. South America Diagnostic Nuclear Medicines Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Diagnostic Nuclear Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Diagnostic Nuclear Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Diagnostic Nuclear Medicines Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Diagnostic Nuclear Medicines Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Diagnostic Nuclear Medicines Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Diagnostic Nuclear Medicines Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Diagnostic Nuclear Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Diagnostic Nuclear Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Diagnostic Nuclear Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Diagnostic Nuclear Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Diagnostic Nuclear Medicines in 2021
Figure 78. Manufacturing Process Analysis of Diagnostic Nuclear Medicines
Figure 79. Diagnostic Nuclear Medicines Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source